Climate change puts Lyme disease in focus for France's Valneva after COVID blow The Lyme disease vaccine trial will start in the coming weeks, involving at least 5,000 people over the age of five. World 08 Aug, 2022
Pfizer says 3 COVID shots protect children under 5 Pfizer says 3 COVID shots protect children under 5 World 23 May, 2022
What is the new COVID-19 variant BA.2, and will it cause another wave of infections in the US? Some scientists have called BA.2 a “stealth” variant because, unlike the BA.1 variant, it lacks a particular genetic signature that distinguishes it from the delta variant. World 22 Mar, 2022
93 per cent target group vaccinated against COVID-19 The government has successfully vaccinated 93 per cent of the target groups against COVID-19. Nepal 21 Mar, 2022
Short AstraZeneca shelf life complicates COVID vaccine rollout to world's poorest BRUSSELS/LONDON, FEBRUARY 16The relatively short shelf life of AstraZeneca Plc's COVID-19 vaccine is complicating the rollout to the world's poorest nations, according to officials and internal World Health Organization documents reviewed by... World 16 Feb, 2022
AstraZeneca sees higher 2022 sales, but COVID boost waning AstraZeneca forecast higher 2022 sales and raised its annual dividend for the first time in a decade on Thursday after beating fourth-quarter profit expectations, but warned the boost from its COVID-19 products would fall. COVID-19 10 Feb, 2022
Health secretary backs decision on Covishield as common booster dose Secretary at the Ministry of Health and Population Roshan Pokharel said that he was not opposed to the ministry’s recent decision to use Covishield as the common COVID booster dose for those above 60 and the ones with compromised immunity. Nepal 05 Feb, 2022
EDITORIAL - Heterologous vaccine As recommended by the World Health Organisation (WHO) and National Immunisation Advisory Committee, the Ministry of Health and Population on Tuesday decided to use Covishield/AstraZeneca vaccine as a booster dose for people above 60 years of age even though they had received other doses – Moderna, Pfizer or VeroCell – during the first and second shots. Opinion 03 Feb, 2022
Covishield to be common booster for all above 60 The Ministry of Health and Population has decided to use Covishield/AstraZeneca vaccine as the booster shot for people above 60 years of age even if they had received other shots — Moderna, Pfizer, or Vero Cell — in the past. Nepal 02 Feb, 2022
Government starts providing 'booster' dose to elderly The government has started administering booster dose vaccine against coronavirus to senior citizens aged above 60. Nepal 30 Jan, 2022
World Bank-financed Moderna vaccines arrive in Nepal to protect children and youth from COVID-19 World Bank-financed Moderna vaccines arrive in Nepal to protect children and youth from COVID-19 Nepal 25 Jan, 2022
Over 1.6 million doses of Moderna vaccine arrive in Nepal More than 1.6 million doses of Moderna vaccine against coronavirus has arrived in Nepal. Kathmandu 25 Jan, 2022
